Telix Launches New Prostate Cancer Imaging Agent, Gozellix, in U.S.

Go back to Telix Launches New Prostate Cancer Imaging Agent, Gozellix, in U.S.
TRANS-LUX CORPORATION (NASDAQ: TLX) Delayed: 11.02 -0.32 (2.82%)
Previous Close $11.34    52 Week High $2.18 
Open $11.23    52 Week Low $0.30 
Day High $11.23    P/E N/A 
Day Low $11.00    EPS $-3.32 
Volume 96,027       

TRANS-LUX CORPORATION (NASDAQ: TLX) Delayed: 11.02 -0.32 (2.82%)
Previous Close $11.34    52 Week High $2.18 
Open $11.23    52 Week Low $0.30 
Day High $11.23    P/E N/A 
Day Low $11.00    EPS $-3.32 
Volume 96,027